Cargando…

Expression Analysis and Mutational Status of Histone Methyltransferase KMT2D at Different Upper Tract Urothelial Carcinoma Locations

The gene coding for histone methyltransferase KMT2D is found among the top mutated genes in upper tract urothelial carcinoma (UTUC); however, there is a lack of data regarding its association with clinicopathologic features as well as survival outcomes. Therefore, we aimed to investigate KMT2D expre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Laukhtina, Ekaterina, Lemberger, Ursula, Bruchbacher, Andreas, Ilijazi, Dafina, Korn, Stephan, Berndl, Florian, D’Andrea, David, Susani, Martin, Enikeev, Dmitry, Compérat, Eva, Shariat, Shahrokh F., Hassler, Melanie R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625702/ https://www.ncbi.nlm.nih.gov/pubmed/34834500 http://dx.doi.org/10.3390/jpm11111147

Ejemplares similares

Discovery of Molecular DNA Methylation-Based Biomarkers through Genome-Wide Analysis of Response Patterns to BCG for Bladder Cancer
por: Ilijazi, Dafina, et al.
Publicado: (2020)

Evaluation of APOBEC3 expression as prognostic marker in squamous cell carcinoma of the penis
por: Trimmel, Bettina, et al.
Publicado: (2022)

Blood-Based Biomarkers as Prognostic Factors of Recurrent Disease after Radical Cystectomy: A Systematic Review and Meta-Analysis
por: Ofner, Heidemarie, et al.
Publicado: (2023)

Detection of Urothelial Bladder Cancer Based on Urine and Tissue Telomerase Activity Measured by Novel RT-TRAP-2PCR Method
por: Glukhov, Alexander, et al.
Publicado: (2021)

Need for and extent of lymph node dissection for upper tract urothelial carcinoma: an updated review in 2023
por: Yanagisawa, Takafumi, et al.
Publicado: (2023)

Histone methyltransferase KMT2D contributes to the protection of myocardial ischemic injury
por: Liu, Shu-Bao, et al.
Publicado: (2022)

The recurrence and progression risk after simultaneous endoscopic surgery of urothelial bladder tumour and benign prostatic hyperplasia: a systematic review and meta‐analysis
por: Sari Motlagh, Reza, et al.
Publicado: (2020)

Preoperative plasma level of endoglin as a predictor for disease outcomes after radical cystectomy for nonmetastatic urothelial carcinoma of the bladder
por: Laukhtina, Ekaterina, et al.
Publicado: (2021)

Cancer-epigenetic function of the histone methyltransferase KMT2D and therapeutic opportunities for the treatment of KMT2D-deficient tumors
por: Dhar, Shilpa S., et al.
Publicado: (2021)

Analysis of the role of mutations in the KMT2D histone lysine methyltransferase in bladder cancer
por: Ding, Beichen, et al.
Publicado: (2019)

Aberrant Activity of Histone–Lysine N-Methyltransferase 2 (KMT2) Complexes in Oncogenesis
por: Poreba, Elzbieta, et al.
Publicado: (2020)

Epigenetic Deregulation of the Histone Methyltransferase KMT5B Contributes to Malignant Transformation in Glioblastoma
por: López, Virginia, et al.
Publicado: (2021)

ASO Author Reflections: Is Vascular Cell Adhesion Molecule-1 (VCAM-1) a Promising Biomarker in Urothelial Carcinoma of the Bladder?
por: Mori, Keiichiro, et al.
Publicado: (2022)

CDC20 Is Regulated by the Histone Methyltransferase, KMT5A, in Castration-Resistant Prostate Cancer
por: Alebady, Zainab A. H., et al.
Publicado: (2023)

KMT1 family methyltransferases regulate heterochromatin–nuclear periphery tethering via histone and non‐histone protein methylation
por: Rao, Radhika Arasala, et al.
Publicado: (2019)

Modes of Interaction of KMT2 Histone H3 Lysine 4 Methyltransferase/COMPASS Complexes with Chromatin
por: Bochyńska, Agnieszka, et al.
Publicado: (2018)

Loss of Function of the Gene Encoding the Histone Methyltransferase KMT2D Leads to Deregulation of Mitochondrial Respiration
por: Pacelli, Consiglia, et al.
Publicado: (2020)

The histone methyltransferase MLL1/KMT2A in monocytes drives coronavirus-associated coagulopathy and inflammation
por: Sharma, Sriganesh B., et al.
Publicado: (2023)

Histone Methyltransferase KMT2B Promotes Metastasis and Angiogenesis of Cervical Cancer by Upregulating EGF Expression
por: Zhao, Dan, et al.
Publicado: (2023)

A panel of systemic inflammatory response biomarkers for outcome prediction in patients treated with radical cystectomy for urothelial carcinoma
por: Schuettfort, Victor M., et al.
Publicado: (2021)

KMT2A histone methyltransferase contributes to colorectal cancer development by promoting cathepsin Z transcriptional activation
por: Fang, Yang, et al.
Publicado: (2019)

Prognostic Role of Preoperative Vascular Cell Adhesion Molecule-1 Plasma Levels in Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy
por: Mori, Keiichiro, et al.
Publicado: (2022)

Update on systemic treatment of upper tract urothelial carcinoma: a narrative review of the literature
por: Gust, Kilian M., et al.
Publicado: (2021)

Functional convergence of histone methyltransferases EHMT1 and KMT2C involved in intellectual disability and autism spectrum disorder
por: Koemans, Tom S., et al.
Publicado: (2017)

Histone methyltransferase KMT2D sustains prostate carcinogenesis and metastasis via epigenetically activating LIFR and KLF4
por: Lv, Shidong, et al.
Publicado: (2017)

The histone methyltransferase KMT2D, mutated in Kabuki syndrome patients, is required for neural crest cell formation and migration
por: Schwenty-Lara, Janina, et al.
Publicado: (2020)

Depletion of histone methyltransferase KMT9 inhibits lung cancer cell proliferation by inducing non-apoptotic cell death
por: Baumert, Hannah Maria, et al.
Publicado: (2020)

Histone Methyltransferase KMT2D Regulates H3K4 Methylation and is Involved in the Pathogenesis of Ovarian Cancer
por: Li, Ming, et al.
Publicado: (2021)

Loss of Histone Methyltransferase KMT2D Attenuates Angiogenesis in the Ischemic Heart by Inhibiting the Transcriptional Activation of VEGF-A
por: Meng, Xiang-Min, et al.
Publicado: (2023)

Impact of the Level of Urothelial Carcinoma Involvement of the Prostate on Survival after Radical Cystectomy
por: Moschini, Marco, et al.
Publicado: (2017)

Urethrectomy at the time of radical cystectomy for non-metastatic urothelial carcinoma of the bladder: a collaborative multicenter study
por: Laukhtina, Ekaterina, et al.
Publicado: (2022)

Prognostic role of the systemic immune–inflammation index in upper tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaboration
por: Mori, Keiichiro, et al.
Publicado: (2021)

Genetic mutational status of genes regulating epigenetics: Role of the histone methyltransferase KMT2D in triple negative breast tumors
por: Morcillo-Garcia, Sara, et al.
Publicado: (2019)

KMT2C, a histone methyltransferase, is mutated in a family segregating non-syndromic primary failure of tooth eruption
por: Assiry, Ali A., et al.
Publicado: (2019)

Histone methyltransferase KMT2D mediated lipid metabolism via peroxisome proliferator-activated receptor gamma in prostate cancer
por: Zhai, Qiliang, et al.
Publicado: (2022)

Further Understanding of Urokinase Plasminogen Activator Overexpression in Urothelial Bladder Cancer Progression, Clinical Outcomes and Potential Therapeutic Targets
por: Grossmann, Nico C, et al.
Publicado: (2021)

Building bridges in urothelial carcinoma to face common challenges
por: Mathieu, Romain, et al.
Publicado: (2016)

Contemporary concepts and controversies in the diagnosis and management of urothelial carcinoma
por: Shariat, Shahrokh F., et al.
Publicado: (2016)

Biological and prognostic implications of biopsy upgrading for high‐grade upper tract urothelial carcinoma at nephroureterectomy
por: Katayama, Satoshi, et al.
Publicado: (2022)

The Fusarium graminearum Histone H3 K27 Methyltransferase KMT6 Regulates Development and Expression of Secondary Metabolite Gene Clusters
por: Connolly, Lanelle R., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_2pp9ri8ga48ma2fednvmvvfdo2